RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
  Bone Cancer
  Breast Cancer
  Cervical Cancer
  Gastric Cancer
  Liver Cancer
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Testicular Cancer
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Radiotherapy Channel

subscribe to Radiotherapy newsletter
Latest Research : Cancer : Therapy : Radiotherapy

   EMAIL   |   PRINT
Radiotherapy timings for colon cancer may need adjustments

Apr 9, 2006 - 9:58:00 AM , Reviewed by: Vineet Gupta
"If you are giving radiation once a day, it shouldn't be a problem. But if you are fractionating treatments, given it two or three times a day, this finding could have implications"

[RxPG] Scientists have unexpectedly discovered that mice with the gene defect that causes colon cancer in humans can differ from normal mice in how they respond to radiation treatments. The large intestine carrying the gene defect in mice that received staggered doses of radiation was three to four times more resistant to the radiation than in control mice.

The researchers, led by Bruce Boman, M.D., Ph.D., director of the Division of Genetic and Preventive Medicine at Jefferson Medical College Philadelphia and at Jefferson's Kimmel Cancer Center and Dennis Leeper, Ph.D., professor of radiation oncology at Jefferson Medical College, say these results may have implications for treating patients with colon cancer, which is a tumor that frequently has mutations in a gene called APC.

Scientists have known that patients' colon tumors with APC mutations have an increased amount of survivin, a protein that halts apoptosis, the programmed cell death. This increase also appears to be associated with a rise in the number of stem cells found at the bottom of colonic crypts. Researchers wanted to see if there was a difference in stem cell number between normal mice and mice mutant for APC. To do this, they exposed both normal and mutant mice to radiation, testing their ability to repair the resulting DNA damage. They speculated that increased survivin in the mutant mice might enable more stem cells to survive and affect the response to radiation. The researchers asked if mice with an APC mutation are different from normal mice in radiation sensitivity and their ability to repair the damage. Normal cells can repair DNA damage from radiation, Dr. Leeper explains.

They measured the survival of colon crypts in the small and large intestines in normal and mutant mice following radiation exposure, looking at the responses to both single doses of radiation and to staggered or "fractionated" doses of radiation, where the second dose is given five hours after the first dose, again causing the DNA repair to kick in.

"In the normal mouse the radiation-induced damage in the intestine is repaired, just as we expected," Dr. Boman explains. In fact, intestinal cells in both the mutant mouse and normal mouse reacted the same to the single dose of radiation.

But the mutant mice responded differently to the staggered radiation. "When we irradiate five hours later when repair has begun, and damage is being repaired, and then a second dose of radiation is given, the mutant mice are resistant," says Dr. Leeper. More specifically, the Jefferson team found that in the large intestine in the mutant mice, the colon crypt cells were more resistant to radiation by a factor of three to four.

"This is a novel finding." says Dr. Leeper . He notes that the results could have important implications as to how radiation is given to colon cancer patients. "If you are giving radiation once a day, it shouldn't be a problem. But if you are fractionating treatments, given it two or three times a day, this finding could have implications. We would want to make sure that repair processes and signaling receptors come back to baseline before a second dose of chemotherapy is given."

Publication: Thomas Jefferson University
On the web: www.jeffersonhospital.org 

Advertise in this space for $10 per month. Contact us today.

Related Radiotherapy News
Microbeam Radiation Therapy (MRT) Could Improve Cancer Treatment
Radiotherapy timings for colon cancer may need adjustments
Irradiation impairs reading development of young children
Helical Tomotherapy : Most Advanced form of Image-Guided Intensity Modulated Radiation Therapy
Electronic Brachytherapy : The Next Generation Radiotherapy
A Technologically Advanced Tool for Difficult-to-Treat Cancers
Timing appears essential to combining antiangiogenesis and radiation therapy

Subscribe to Radiotherapy Newsletter

Enter your email address:

 Additional information about the news article
Findings were reported at the 2006 annual meeting of the American Association for Cancer Research in Washington, D.C. (Stem Cell Number and Radiation Resistance During Repair in Colonic Crypts of APC Mice: Abstract no. LB-311).
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)